for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Xiamen Kingdomway Group Co

002626.SZ

Latest Trade

33.28CNY

Change

-0.02(-0.06%)

Volume

4,641,453

Today's Range

32.90

 - 

33.50

52 Week Range

18.00

 - 

64.48

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
33.30
Open
33.09
Volume
4,641,453
3M AVG Volume
184.63
Today's High
33.50
Today's Low
32.90
52 Week High
64.48
52 Week Low
18.00
Shares Out (MIL)
609.93
Market Cap (MIL)
20,516.52
Forward P/E
16.77
Dividend (Yield %)
1.80

Next Event

Q4 2020 Xiamen Kingdomway Group Co Earnings Release

Latest Developments

More

Xiamen Kingdomway Group To Buy 86% Stake In Pharma Firm For 307.3 Mln Yuan

Xiamen Kingdomway Group Sees Jan-Sept Net Profit Up 40-60% Y/Y

Xiamen Kingdomway's Controlling Shareholder To Unload Up To 2% Stake In Company

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Xiamen Kingdomway Group Co

Xiamen Kingdomway Group Company is a China-based company principally engaged in the production and distribution of nutrition enhancers and health care products. The Company mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The Company distributes its products within domestic market and to overseas markets.

Industry

Major Drugs

Contact Info

NA02

XIAMEN, FUJ

361028

China

+86.592.3781760

http://www.kingdomway.com

Executive Leadership

Bin Jiang

Chairman of the Board, General Manager

Hang Hong

Chief Financial Officer, Deputy General Manager

Jialiang Chen

Executive Deputy General Manager, Director

Guoqing Ma

Deputy General Manager, Director

Guanghuang Zhan

Deputy General Manager

Key Stats

1.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2017

2.1K

2018

2.9K

2019

3.2K

2020(E)

3.9K
EPS (CNY)

2017

0.770

2019

0.730

2020(E)

1.985
Price To Earnings (TTM)
28.37
Price To Sales (TTM)
5.92
Price To Book (MRQ)
6.18
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
25.13
LT Debt To Equity (MRQ)
12.96
Return on Investment (TTM)
19.01
Return on Equity (TTM)
15.39

Latest News

Latest News

BRIEF-Xiamen Kingdomway's Controlling Shareholder To Unload Up To 2% Stake In Company

* SAYS ITS CONTROLLING SHAREHOLDER PLANS TO UNLOAD UP TO 2% STAKE IN COMPANY WITHIN SIX MONTHS Source text in Chinese: https://bit.ly/2UWuntA Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Xiamen Kingdomway Group Sees Q1 Net Profit Up 30-80% Y/Y

* SAYS IT SEES Q1 NET PROFIT UP 30-80% Y/Y FROM 131.1 MILLION YUAN ($18.50 million) YEAR EARLIER Source text in Chinese: https://bit.ly/2y7NY2d Further company coverage: ($1 = 7.0863 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up